BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 29426745)

  • 21. The role of vaginal cuff brachytherapy in endometrial cancer.
    Harkenrider MM; Block AM; Siddiqui ZA; Small W
    Gynecol Oncol; 2015 Feb; 136(2):365-72. PubMed ID: 25555710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant radiotherapy for stage I endometrial cancer.
    Kong A; Johnson N; Kitchener HC; Lawrie TA
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003916. PubMed ID: 22513918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel low dose fractionation regimen for adjuvant vaginal brachytherapy in early stage endometrioid endometrial cancer.
    Townamchai K; Lee L; Viswanathan AN
    Gynecol Oncol; 2012 Nov; 127(2):351-5. PubMed ID: 22850411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer.
    van den Heerik ASVM; Horeweg N; Nout RA; Lutgens LCHW; van der Steen-Banasik EM; Westerveld GH; van den Berg HA; Slot A; Koppe FLA; Kommoss S; Mens JWM; Nowee ME; Bijmolt S; Cibula D; Stam TC; Jurgenliemk-Schulz IM; Snyers A; Hamann M; Zwanenburg AG; Coen VLMA; Vandecasteele K; Gillham C; Chargari C; Verhoeven-Adema KW; Putter H; van den Hout WB; Wortman BG; Nijman HW; Bosse T; Creutzberg CL
    Int J Gynecol Cancer; 2020 Dec; 30(12):2002-2007. PubMed ID: 33046573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer.
    Solhjem MC; Petersen IA; Haddock MG
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1379-84. PubMed ID: 16029796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaginal brachytherapy for endometrial cancer.
    Hass P; Seinsch S; Eggemann H; Ignatov T; Seitz S; Ignatov A
    J Cancer Res Clin Oncol; 2018 Aug; 144(8):1523-1530. PubMed ID: 29730776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation.
    McCloskey SA; Tchabo NE; Malhotra HK; Odunsi K; Rodabaugh K; Singhal P; Lele S; Jaggernauth W
    Gynecol Oncol; 2010 Mar; 116(3):404-7. PubMed ID: 19944453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-Dose Adjuvant Cylinder Brachytherapy for Endometrioid Endometrial Cancer.
    Alban GM; Buscariollo DL; Cheng T; Pretz J; Krechmer B; Buzurovic I; Singer L; King M; Lee L
    Pract Radiat Oncol; 2020; 10(2):95-103. PubMed ID: 31783169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer.
    Lin LL; Mutch DG; Rader JS; Powell MA; Grigsby PW
    Gynecol Oncol; 2007 Jul; 106(1):215-20. PubMed ID: 17482665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overview of adjuvant radiotherapy on survival, failure pattern and toxicity in stage I to II endometrial carcinoma: a long-term multi-institutional analysis in China.
    Wang W; Wang T; Liu Z; He J; Sun X; Zhong W; Zhao F; Li X; Li S; Zhu H; Ma Z; Hu K; Zhang F; Hou X; Wei L; Zou L
    BMC Cancer; 2022 Mar; 22(1):266. PubMed ID: 35287626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant vaginal brachytherapy and chemotherapy versus pelvic radiotherapy in early-stage endometrial cancer: Outcomes by risk factors.
    Tatebe K; Hasan Y; Son CH
    Gynecol Oncol; 2019 Dec; 155(3):429-435. PubMed ID: 31610885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of disease recurrence between robotic versus laparotomy approach in patients with intermediate-risk endometrial cancer.
    Song J; Le T; Hopkins L; Fung-Kee-Fung M; Lupe K; Gaudet M; E C; Samant R
    Int J Gynecol Cancer; 2020 Feb; 30(2):160-166. PubMed ID: 31871112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiation therapy improves disease-specific survival in women with Stage II endometrioid endometrial cancer-Brachytherapy may be sufficient.
    Nwachukwu CR; Von-Eyben R; Kidd EA
    Brachytherapy; 2018; 17(2):383-391. PubMed ID: 29198879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Off-study utilization of experimental therapies: Analysis of GOG249-eligible cohorts using real world data.
    Chodavadia PA; Jacobs CD; Wang F; Havrilesky LJ; Chino JP; Suneja G
    Gynecol Oncol; 2020 Jan; 156(1):154-161. PubMed ID: 31759772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravaginal 1-week high-dose-rate brachytherapy alone for Stages I-II endometrial cancer.
    Martínez-Monge R; Nagore G; Cambeiro M; Garrán C; Villafranca E; Jurado M
    Brachytherapy; 2007; 6(3):195-200. PubMed ID: 17681240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors Predictive of Receiving Adjuvant Radiotherapy in High-Intermediate-Risk Stage I Endometrial Cancer.
    McGunigal M; Pollock A; Doucette JT; Liu J; Chadha M; Kalir T; Gupta V
    Int J Gynecol Cancer; 2018 Jun; 28(5):882-889. PubMed ID: 29538253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study.
    Sorbe B; Nordström B; Mäenpää J; Kuhelj J; Kuhelj D; Okkan S; Delaloye JF; Frankendal B
    Int J Gynecol Cancer; 2009 Jul; 19(5):873-8. PubMed ID: 19574776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stage II endometrial carcinoma: limiting post-operative radiotherapy to the vaginal vault in node-negative tumors.
    Rittenberg PV; Lotocki RJ; Heywood MS; Krepart GV
    Gynecol Oncol; 2005 Sep; 98(3):434-8. PubMed ID: 16005498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant Chemotherapy and Vaginal Vault Brachytherapy With or Without Pelvic Radiotherapy for Stage 1 Papillary Serous or Clear Cell Endometrial Cancer.
    Tétreault-Laflamme A; Nguyen-Huynh TV; Carrier JF; Samouëlian V; Sauthier P; Beauchemin MC; Barkati M
    Int J Gynecol Cancer; 2016 Feb; 26(2):301-6. PubMed ID: 26745699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment optimization of pelvic external beam radiation and/or vaginal brachytherapy for patients with stage I to II high-risk Endometrioid adenocarcinoma: a retrospective multi-institutional analysis.
    Wang W; Zou L; Wang T; Liu Z; He J; Sun X; Zhong W; Zhao F; Li X; Li S; Zhu H; Ma Z; Sun S; Jin M; Zhang F; Hou X; Wei L; Hu K
    BMC Cancer; 2021 Jul; 21(1):774. PubMed ID: 34217240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.